Literature DB >> 11136492

Lead- and device-related complications in the antiarrhythmics versus implantable defibrillators trial.

J Kron1, J Herre, E G Renfroe, C Rizo-Patron, M Raitt, B Halperin, M Gold, B Goldner, M Wathen, B Wilkoff, A Olarte, Q Yao.   

Abstract

BACKGROUND: Implantation of transvenous implantable cardioverter defibrillators (ICDs) by use of a nonthoracotomy approach has become routine therapy for survivors of life-threatening tachyarrhythmias. The purpose of this study was to identify and prospectively characterize the frequency of lead- and ICD-related complications from the Antiarrhythmics versus Implantable Defibrillators (AVID) Trial. METHODS AND
RESULTS: Between June 1, 1993, and April 7, 1997, 539 patients received nonthoracotomy ICDs either as initial treatment assignment (477) or as crossover from medical management (62). A total of 62 first complications occurred. The subclavian route of insertion resulted in more complications than the cephalic vein route, 46 of 339 (14%) versus 6 of 135 (4%), P = .005, as did the abdominal versus pectoral generator site, 31 of 238 (13%) versus 17 of 291 (6%), P<.02. Most dislodgements and system infections tended to occur in the 3 months after implantation, whereas lead fractures continued to occur throughout follow-up. Failure to use perioperative antibiotics was a predictor of system infection (P = .001).
CONCLUSIONS: These data suggest that cephalic vein access and pectoral generator site may result in fewer complications. The continued occurrence of lead fractures and the need for premature system revision supports the practice of close routine ICD system surveillance.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11136492     DOI: 10.1067/mhj.2001.111261

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  22 in total

1.  The Entirely Subcutaneous Defibrillator - A New Generation and Future Expectations.

Authors:  Hussam Ali; Pierpaolo Lupo; Riccardo Cappato
Journal:  Arrhythm Electrophysiol Rev       Date:  2015-08

2.  Prophylactic ICDs: can (and will) the medical marketplace decide their role?

Authors:  Sanjeev Saksena
Journal:  J Interv Card Electrophysiol       Date:  2005-04       Impact factor: 1.900

3.  The leadless defibrillator or the return of the subcutaneous electrode: episode III in the ICD saga?

Authors:  Sanjeev Saksena
Journal:  J Interv Card Electrophysiol       Date:  2005-09       Impact factor: 1.900

4.  Remote monitoring in implantable defibrillator therapy.

Authors:  D A M J Theuns; L S Jordaens
Journal:  Neth Heart J       Date:  2008-02       Impact factor: 2.380

Review 5.  Current state of knowledge and experts' perspective on the subcutaneous implantable cardioverter-defibrillator.

Authors:  Massimo Santini; Riccardo Cappato; Dietrich Andresen; Johannes Brachmann; D Wyn Davies; John Cleland; Alessandro Filippi; Edoardo Gronda; Richard Hauer; Gerhard Steinbeck; David Steinhaus
Journal:  J Interv Card Electrophysiol       Date:  2009-03-06       Impact factor: 1.900

6.  Unexpected early complication of implantable-cardioverter defibrillator.

Authors:  Ahmed Abdelhafez; Nancy Wassef; Kai Hogrefe; Mohsin Farooq
Journal:  BMJ Case Rep       Date:  2018-06-06

Review 7.  Subcutaneous chronic implantable defibrillation systems in humans.

Authors:  Riccardo Cappato; Warren M Smith; Margaret A Hood; Ian G Crozier; Luc Jordaens; Stefan G Spitzer; Andrey V Ardashev; Lucas Boersma; Pierpaolo Lupo; Andrew A Grace; Gust H Bardy
Journal:  J Interv Card Electrophysiol       Date:  2012-03-17       Impact factor: 1.900

8.  Determinants of outcomes following outpatient placement of implantable cardioverter defibrillators in a Medicare Advantage population.

Authors:  Teresa L Rogstad; Adam C Powell; Yongjia Song; Tristan Cordier; Stephen E Price; James W Long; Uday U Deshmukh; Jeffrey D Simmons
Journal:  Clin Cardiol       Date:  2018-09-20       Impact factor: 2.882

9.  Unusual chest pain syndromes caused by implanted cardiac device leads: a case series.

Authors:  Chance M Witt; Patricia J M Best; Samuel J Asirvatham; Christopher J McLeod
Journal:  J Interv Card Electrophysiol       Date:  2013-12-11       Impact factor: 1.900

10.  Loss of capture late after right ventricular pacing lead revision: what is the mechanism?

Authors:  Joachim Seegers; Lars Lüthje; Markus Zabel; Dirk Vollmann
Journal:  Clin Res Cardiol       Date:  2009-06-25       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.